TSCL also announced its support this week for the Medicare Prescription Drug Price Negotiation Act (S. 41, H.R. 242), which was introduced by Senator Amy Klobuchar (MN) in the Senate and by Representative Peter Welch (VT) in the House. Their bill, if signed into law, would require the Secretary of the Department of Health and Human Services (HHS) to negotiate prescription drug prices on behalf of nearly 40 million Medicare Part D beneficiaries. If HHS were able to negotiate similar prices as those paid by Medicaid and the Veterans Health Administration, the Medicare program would save billions of dollars annually, and beneficiaries would have better access to more affordable prescription drugs. .This week, Rep. Jo Ann Emerson (MO-8) introduced H.R. 239, The Notch Baby Act. The Notch Baby Act, if signed into law, would grant an improved benefit computation for those born between 1917 and 1926, Notch Babies. The formula is slightly different than that used in Rep. Ralph Hall's (TX-4) Notch Fairness Act and does not have a cap on costs. .To learn more, please visit . .Two weeks after President Trump signed an executive order "Lowering Drug Prices by Putting America First," the White House still has not released the text of the order. The unorthodox move is apparently a leverage play, an attempt to squeeze drug companies into offering concessions. .Also last year, I introduced the Medicare Advantage Coverage Transparency Act which was ultimately passed with unanimous support and then signed into law by President Obama. Decision-making in Washington should be based on transparency. A truly representative legislature should foster a culture of openness, which is why this law now requires the Department of Health and Human Services (HHS) to offer Congress expanded information on Medicare Advantage enrollment each year based on zip code, congressional district, and state. The purpose of this additional data is to provide greater information to the public, to policymakers, and to the health care community so they may have the most up-to-date information when making decisions. .Low-income beneficiaries who receive Medicaid in addition to Medicare. State Medicaid programs pay the Part B premiums for people who qualify due to low income and resources. According to the Kaiser Family Foundation, there are approximately 10 million dually - eligible beneficiaries representing about two-thirds of those who are not protected by hold harmless. .Low-income seniors and disabled adults who qualify for benefits under both Medicare and Medicaid frequently have multiple chronic health problems, and more than half have cognitive or mental impairments. More than half of dual eligibles also have annual incomes of less than ,000, and are more likely to receive nursing .Medicare health plans also have new rules about co-pays and co-insurance. Copayments can vary drastically between MA plans, but through 2018, individual plans were required to offer all enrollees in the plan's service area access to the same benefits at the same level of cost - sharing. In 2019, MA plans have the option of imposing tiers for the cost - sharing of contracted providers, as an incentive to encourage enrollees to seek care from specific providers. Plans that utilize tiered cost-sharing must disclose tiered co-pays and co-insurance amounts to enrollees and providers, ensure that services at each tier of cost-sharing are available to all enrollees, and ensure that all enrollees are charged the same amount for the same service from the same provider. .In a recent survey of TSCL's supporters, as many as one-third of respondents said they postponed filling their prescriptions or took less than prescribed due to high costs. They question why Congress hasn't taken action to improve the system and to protect the American public from rising drug costs.